NCT04497116
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04497116
Title Study of RP-3500 in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Repare Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | DNK | CAN

Facility Status City State Zip Country Details
#1014, Northwestern University Chicago Illinois 60611 United States Details
#1006, Massachusetts General Hospital Boston Massachusetts 02114 United States Details
#1002, Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
#1004, Memorial Sloan Kettering Cancer Institute New York New York 10065 United States Details
#1005, Duke Cancer Institute Durham North Carolina 27710 United States Details
#1007, Rhode Island Hospital Providence Rhode Island 02903 United States Details
#1003, Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
#1001, The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
#2001, Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
#4001, Copenhagen University Hospital Rigshospitalet - Blegdamsvej Copenhagen DK 2100 Ø Denmark Details
#3003, Sarah Cannon Research Institute London W1G 6AD United Kingdom Details
#3001, The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
#3002, Freeman Hospital Newcastle Newcastle upon Tyne NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field